no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
A candidate vaccine based on the hepatitis C E1 protein: tolerability and immunogenicity in healthy volunteers
|
Leroux-Roels, Geert |
|
2004 |
22 |
23-24 |
p. 3080-3086 7 p. |
article |
2 |
Active immunization against murine TNFα peptides in mice: generation of endogenous antibodies cross-reacting with the native cytokine and in vivo protection
|
Capini, C.J |
|
2004 |
22 |
23-24 |
p. 3144-3153 10 p. |
article |
3 |
Adolescent and adult pertussis vaccination: computer simulations of five new strategies
|
Van Rie, Annelies |
|
2004 |
22 |
23-24 |
p. 3154-3165 12 p. |
article |
4 |
Aluminum hydroxide adjuvant induces macrophage differentiation towards a specialized antigen-presenting cell type
|
Rimaniol, Anne-Cécile |
|
2004 |
22 |
23-24 |
p. 3127-3135 9 p. |
article |
5 |
A murine model for the study of immune memory in response to pneumococcal conjugate vaccination
|
Moreno, R.L |
|
2004 |
22 |
23-24 |
p. 3069-3079 11 p. |
article |
6 |
An adenoviral type 5 vector carrying a type 35 fiber as a vaccine vehicle: DC targeting, cross neutralization, and immunogenicity
|
Ophorst, Olga J.A.E |
|
2004 |
22 |
23-24 |
p. 3035-3044 10 p. |
article |
7 |
A phase I study to evaluate a human papillomavirus (HPV) type 18 L1 VLP vaccine
|
Ault, Kevin A |
|
2004 |
22 |
23-24 |
p. 3004-3007 4 p. |
article |
8 |
A preliminary experiment of absorption of antinuclear antibodies by the hepatitis B vaccine components, in a case of neurolupus
|
Poirriez, Jean |
|
2004 |
22 |
23-24 |
p. 3166-3168 3 p. |
article |
9 |
Author Index for Volume 21 (2003)
|
|
|
2004 |
22 |
23-24 |
p. XXIV-XXXIX nvt p. |
article |
10 |
CCR5 targeted SIV vaccination strategy preventing or inhibiting SIV infection
|
Bogers, W.M.J.M. |
|
2004 |
22 |
23-24 |
p. 2974-2984 11 p. |
article |
11 |
Characteristics of Vibrio cholerae proteinases: potential, candidate vaccine antigens
|
Stewart-Tull, D.E.S. |
|
2004 |
22 |
23-24 |
p. 3026-3034 9 p. |
article |
12 |
Editorial Board/Aims and Scope
|
|
|
2004 |
22 |
23-24 |
p. IFC- 1 p. |
article |
13 |
Ethical principles for collective immunisation programmes
|
Verweij, Marcel |
|
2004 |
22 |
23-24 |
p. 3122-3126 5 p. |
article |
14 |
Expression kinetics of the interleukin-2/immunoglobulin (IL-2/Ig) plasmid cytokine adjuvant
|
Barouch, Dan H |
|
2004 |
22 |
23-24 |
p. 3092-3097 6 p. |
article |
15 |
Full-length HIV-1 Tat protein necessary for a vaccine
|
Opi, Sandrine |
|
2004 |
22 |
23-24 |
p. 3105-3111 7 p. |
article |
16 |
Generation of reassortant influenza vaccines by reverse genetics that allows utilization of a DIVA (Differentiating Infected from Vaccinated Animals) strategy for the control of avian influenza
|
Lee, Chang-Won |
|
2004 |
22 |
23-24 |
p. 3175-3181 7 p. |
article |
17 |
Immunostimulatory oligodeoxynucleotides are potent enhancers of protective immunity in mice immunized with recombinant ORFF leishmanial antigen
|
Tewary, Poonam |
|
2004 |
22 |
23-24 |
p. 3053-3060 8 p. |
article |
18 |
Incidence of severe Plasmodium falciparum malaria as a primary endpoint for vaccine efficacy trials in Bandiagara, Mali
|
Lyke, Kirsten E |
|
2004 |
22 |
23-24 |
p. 3169-3174 6 p. |
article |
19 |
Interfering vaccine: a novel antiviral that converts a potentially virulent infection into one that is subclinical and immunizing
|
Noble, Simon |
|
2004 |
22 |
23-24 |
p. 3018-3025 8 p. |
article |
20 |
Intranasal immunization with outer membrane protein P6 and cholera toxin induces specific sinus mucosal immunity and enhances sinus clearance of nontypeable Haemophilus influenzae
|
Sabirov, Albert |
|
2004 |
22 |
23-24 |
p. 3112-3121 10 p. |
article |
21 |
Intravaginal immunization with viral subunit protein plus CpG oligodeoxynucleotides induces protective immunity against HSV-2
|
Kwant, Amanda |
|
2004 |
22 |
23-24 |
p. 3098-3104 7 p. |
article |
22 |
Long-lasting specific antibodies against CETP induced by subcutaneous and mucosal administration of a 26-amino acid CETP epitope carried by heat shock protein 65 kDa in the absence of adjuvants
|
Gaofu, Qi |
|
2004 |
22 |
23-24 |
p. 3187-3194 8 p. |
article |
23 |
Oral polio vaccination and low case fatality at the paediatric ward in Bissau, Guinea-Bissau
|
Aaby, Peter |
|
2004 |
22 |
23-24 |
p. 3014-3017 4 p. |
article |
24 |
PorA-specific differences in antibody avidity after vaccination with a hexavalent Men B outer membrane vesicle vaccine in toddlers and school children
|
Vermont, C.L |
|
2004 |
22 |
23-24 |
p. 3008-3013 6 p. |
article |
25 |
Potent immunogenicity of DNA vaccines encoding Plasmodium vivax transmission-blocking vaccine candidates Pvs25 and Pvs28—evaluation of homologous and heterologous antigen-delivery prime-boost strategy
|
Kongkasuriyachai, Darin |
|
2004 |
22 |
23-24 |
p. 3205-3213 9 p. |
article |
26 |
Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys
|
Fan, Jiang |
|
2004 |
22 |
23-24 |
p. 2993-3003 11 p. |
article |
27 |
Prediction of CTL epitopes using QM, SVM and ANN techniques
|
Bhasin, Manoj |
|
2004 |
22 |
23-24 |
p. 3195-3204 10 p. |
article |
28 |
Reactions after pneumococcal vaccine alone or in combination with influenza vaccine
|
Sočan, Maja |
|
2004 |
22 |
23-24 |
p. 3087-3091 5 p. |
article |
29 |
Recombinant cholera toxin B subunit (rCTB) as a mucosal adjuvant enhances induction of diphtheria and tetanus antitoxin antibodies in mice by intranasal administration with diphtheria–pertussis–tetanus (DPT) combination vaccine
|
Isaka, Masanori |
|
2004 |
22 |
23-24 |
p. 3061-3068 8 p. |
article |
30 |
Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine
|
Cooper, C.L |
|
2004 |
22 |
23-24 |
p. 3136-3143 8 p. |
article |
31 |
Safety and immunogenicity of intranasal murine parainfluenza virus type 1 (Sendai virus) in healthy human adults
|
Slobod, Karen S |
|
2004 |
22 |
23-24 |
p. 3182-3186 5 p. |
article |
32 |
Subject Index for Volume 21 (2003)
|
|
|
2004 |
22 |
23-24 |
p. I-XXIII nvt p. |
article |
33 |
Systematic review of the effects of pertussis vaccines in children
|
Simondon, François |
|
2004 |
22 |
23-24 |
p. 2965- 1 p. |
article |
34 |
The effectiveness of pneumococcal polysaccharide vaccines in adults: a systematic review of observational studies and comparison with results from randomised controlled trials
|
Conaty, Stephen |
|
2004 |
22 |
23-24 |
p. 3214-3224 11 p. |
article |
35 |
Therapeutic immunization with an inactivated HIV-1 Immunogen plus antiretrovirals versus antiretroviral therapy alone in asymptomatic HIV-infected subjects
|
Fernandez-Cruz, E |
|
2004 |
22 |
23-24 |
p. 2966-2973 8 p. |
article |
36 |
Vaccination of high-risk patients against influenza: impact on primary care contact rates during epidemics
|
Tacken, M.A.J.B |
|
2004 |
22 |
23-24 |
p. 2985-2992 8 p. |
article |
37 |
Very small size proteoliposomes derived from Neisseria meningitidis: an effective adjuvant for Th1 induction and dendritic cell activation
|
Mesa, Circe |
|
2004 |
22 |
23-24 |
p. 3045-3052 8 p. |
article |